Union for International Cancer Control (UICC)
Last Modified: January 19, 2012
Dates: August 27-30, 2012
Location: Montréal, Canada
Sponsoring Group: Union for International Cancer Control (UICC)
Web Page: www.worldcancercongress.org
Topics Covered: Track 1 Prevention and early detection Session topics include:
Alcohol and cancer Track 2 - Cancer care and survivorship Session topics include:
Social media in cancer care and support Track 3 - Palliation and pain control Session topics include:
Paediatric cancer pain Track 4 - Systems in cancer control Session topics include:
Objectives: Connecting for global impact - attended by cancer professionals from the entire spectrum of the cancer community, the programme incorporates a range of disciplines: from prevention, the continuum of care, health systems, to basic and clinical research.
Who Should Attend: Professionals in cancer control, research and programme implementation who wish to expand their knowledge on new prevention and early detection strategies. Individuals engaged in cancer care including researchers, healthcare professionals, volunteers, patient support teams, advocacy groups, cancer networks and survivors. Professionals and volunteers engaged in palliative care, symptom and pain control. Cancer control researchers and programme implementers. Professionals and volunteers, engaged in programme monitoring and evaluation, fundraising, advocacy, policy work or governance will also find value in attending.
Registration Information: First column: Early Bird rate until 22 April 2012 Second column: Regular rate until 31 July 2012 Third column: On-site rate until 15 August 2012 UICC Members* $490 $720 $820 UCC Association of Fewllowships $490 $720 $820 Non Members $780 $920 $970 Nurses/students** $490 $720 $820 One day registration $400 $450 $480 Accompanying guest $190 $210 $230. Visit www.worldcancercongress.org/registration
Continuing Education: Yes
Jun 4, 2013 - Over 90 percent of oncologists in the United States reported that shortages of cancer drugs between March and September 2012 affected patient treatment, forcing them to switch to more expensive drugs and generally compromising patient care, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Jun 4, 2013
Jan 2, 2013
Dec 17, 2012
Dec 13, 2012
Dec 4, 2012
Nov 2, 2012